biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > BTI tweets:

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon May 16, 2023 5:47pm

87 Views

Post# 35451239

RE:RE:RE:RE:RE:RE:BTI tweets:

Yes I agree but ...

Not with BTI at this time.

Take a look at the number of shares traded lately
Even if you made 50% on your trade it's not even worth talking about!

BUT if u are a gambler and willing to buy and HOLD then there a chance to make some $ even big $!

As an example I did very well as a lot of investors with C.SONA but then the bottom fell out of it.

I didn't really follow it anymore. I think it fell as low as 2 cents (going by memory) but then it got a new life and went to 20 cents plus ( going by memory) ( couldn't be bothered to check).

SO the same thing could happen with BTI! Are you that gambler?

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload